Schenectady County Suing Pharmaceutical Companies Over Opioid Crisis

Roquette, the France-based supplier of plant-based ingredients for food, nutrition and health markets, has launched two new wheat-free directly compressible grades of Mannitol/a>. Mumbai-based Signet Chemical Corporation Pvt. Ltd. is the authorised distributor for the products in India.
The company has been investing in excipient innovation for the growing nutraceutical industry. It is seeking to address the growing consumer preference for clean label products like natural, organic, allergen-free, where in gluten-free products are also being increasingly preferred by consumers in general and particularly by those with dietary restrictions or celiac diseases.
According to Roquette, the two new grades – Pearlitol SW-F 100 and Pearlitol SW-F 200 – have comparable direct compression performance as that of Pearlitol 100 SD and Pearlitol 200 SD (spray-dried mannitol) grades, which are the preferred excipients due to properties like optimum flow, compressibility, high chemical compati-bility and non-hygroscopicity. Spray-dried mannitol is soluble in nature, has absence of unstable crystalline form and also has a negative heat of solution, which gives a cooling effect and pleasant taste to nutraceutical tablets.
Roquette offers a broad range of natural, functional filler/binder and taste-masking excipients that provide pleasant taste, mouth-feel and solid or liquid oral dosage form choice (syrup, lozenge, ODT, ODF, effervescent, gummy). With three innovation centres across the globe, Roquette is continuously investing in designing multi-functional excipients and ready to use co-processed platforms to meet customer needs. The company has leveraged its secure global supply chain and scale-up competency in spray-drying to innovate new solutions and have strengthened their position in the nutraceutical industry. Products formulated with the new Pearlitol SW-F grades can be claimed to be gluten-free, tooth-friendly, sugar free and non-GMO, it said.
2026-10-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China’s 15th Five-Year Plan Sets New Priorities for Pharmaceutical Innovation and Supply Chains
-
Evonik Expands Slovakian Fermas Site with €80 Million Investment to Boost Pharmaceutical CDMO Capacity
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
The project of fine chemicals with 4000 t/a Tebuconazole and Diflufenican is to be built
-
Pharmaconex 2022
-
CPHI Korea 2022
-
Shandong Pharmaceutical Companies Grab Over $1 Billion of Antithrombotic Drugs for The First Imitation, Original Research Drugs Soared 5527%
-
ECHEMI International Trade Business School Bangladesh Pharmaceutical Summary
-
Industrialization Progress of genetically modified pharmaceutical products
-
2022 Top 50 Global Pharmaceutical Companies Released! Pfizer Returns to NO.1, Kexing Counterattack First on the List
Recommend Reading
-
25 Companies Raise Prices Three Times Within a Month: China’s Titanium Dioxide Industry Shifts from “Price Wars” to a “Pricing Alliance”
-
Chemical Tanker Explodes Off Oman Coast, Maritime Security Risk Escalates Again
-
South Korea to Impose Anti-Dumping Duties on Caustic Soda: Chinese Mainland Firms Face Up to 22.21%, Taiwan Region 38.89%
-
Brazil Expands Chemical Tax Breaks as India’s Crop Protection Industry Warns of a 25% Cost Increase
-
Death Toll from Fire at China-Russia Amur Polyolefins Project Rises to 15 as Construction Continues
-
Business Society’s Market Outlook for Epoxy Resins on August 28, 2026: Stable Operation
-
Business Society’s Diesel Trend Analysis for September 15, 2026: Volatile Performance
-
Business Society’s BDO Market Outlook on August 27, 2026: Clearly Upward
-
Business Society’s Trend Analysis for Fuel Oil 180CST on September 14, 2026: Volatile Fluctuations
-
Business Society’s Market Outlook for Acetic Acid on August 27, 2026: Deep Correction with a Bearish Bias